Oncology

Your Article Summary

See Latest Articles

Short and long-term advantages of transhiatal and transthoracic oesophageal cancer resection
European Journal of Surgical Oncology, 06/30/09

Omloo JMT et al. - In a review of short and long-term advantages of transhiatal and transthoracic oesophageal cancer resection, this overview describes short- and long-term advantages of these 2 strategies.

• 2 major surgical strategies to improve survival rates after oesophagectomy for oesophageal cancer have emerged during the past decades; (limited) transhiatal oesophagectomy and (extended) transthoracic oesophagectomy with 2-field lymphadenectomy.

• In the short term, transhiatal oesophagectomy is accompanied by less morbidity.
• In the long term, this strategy is only preferable for pts with tumours located at the gastro-oesophageal junction, without involved lymph nodes in the proximal compartment of the chest.
• For pts with tumours located in the oesophagus, the transthoracic route with extended lymphadenectomy is probably preferred, because of improved long-term survival.

Today in GI Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer
Journal of Clinical Oncology, 11/02/09

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer
Journal of Clinical Oncology, 10/29/09

Dose finding and early efficacy study of gemcitabine plus capecitabine in combination with bevacizumab plus erlotinib in advanced pancreatic cancer
Journal of Clinical Oncology, 11/03/09

See All of GI Oncology